Unilateral Vibration Stimulation in Patients With Post-stroke Spasticity Suppresses Muscle Tonus in the Contralateral Homologous Muscles. [PDF]
Kunoh K, Takenaka T, Kimura D, Suzuki T.
europepmc +1 more source
Increasing the Dose of Onabotulinum Toxin A From 400 to 600 Units for Post-stroke Spasticity: A Retrospective Study on Safety and Muscle Selection. [PDF]
Hashimoto G +4 more
europepmc +1 more source
Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report. [PDF]
Sartori F, Puig-Diví A, Picañol J.
europepmc +1 more source
Exploring the Role of Bipolar Thermal Radiofrequency in Complex Multi-pattern Post-stroke Spasticity: Clinical Insights From a Case Report With Combined Botulinum Toxin Type A Therapy. [PDF]
Cordero-García C +3 more
europepmc +1 more source
Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010-2021. [PDF]
Sagerfors M +4 more
europepmc +1 more source
Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis. [PDF]
Hadnorntun P +9 more
europepmc +1 more source
Related searches:
A Modified Scoping Review of Interventions for Global Post Stroke Spasticity.
ToxiconPURPOSE Stroke is a major global health concern, and post-stroke spasticity (PSS) can severely impair mobility and quality of life. This modified scoping review synthesizes the most current evidence up to 2024 for interventions targeting PSS, employing ...
A. Suputtitada +3 more
semanticscholar +1 more source
In post-stroke spasticity (PSS), effective treatment with botulinum neurotoxin (BoNT) is associated with transient decrease in activation of the ipsilesional superior parietal lobule (SPL) and intraparietal sulcus (IPS).
T. Veverka +8 more
semanticscholar +1 more source

